ETC-159 - Experimental Therapeutics Centre, A*Star, National University of Singapore
Keytruda (pembrolizumab) - Merck (MSD)
https://igcsmeeting.com/wp-content/uploads/sites/36/2023/10/IGCS-2023-Abstracts-ePosters.pdf
 
Veronica Diermayr1; David Tan2; Natalie Yan Li Ngoi2; Matthew Ng3; Wells Messersmith4; Bradley Corr5; Weijin Sun6; Venkatheshan Srirangam1; Julienne Cometa1; Stephanie Blanchard1; Ranjani Nellore1; Bong Hwa Gan1; Nurul Rozaini1; Claudia Koh1
 
Oct 25, 2023
 
Prev Next